Expanded Access Study of Iodine-131 Anti-B1 Antibody
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to make Iodine-131 Anti-B1 Antibody more broadly
available to patients. Secondary endpoints of the study will be to obtain additional
information on the efficacy and safety of Iodine-131 Anti-B1 Antibody.